Contact Us

News

  • Plant 3

    OSD and Injectable Oncology - Verna, Goa - Installation completed and under process validation

    2019-04-08 14:55:31

  • Plant 2

    OSD - Skidel, Belarus Inaugurated on 7-Mar-19. Commercial Licence Obtained in Dec-2019

    2020-01-25 10:12:34

  • Plant 4

    ONCO API, Goa - Building is ready, machine installations in progress

    2019-09-24 17:49:06

  • Fight against Covid-19

    Face mask, Two Yard distance and hand wash is must

    2020-10-16 14:21:39

  • DSIR Approved R&D Centre

    R&D and ADL centre has certified by DSIR, Govt. of India.

    2020-10-16 14:22:49

Quote

  • Launch of two products in our brand and for contract manufacturing Oseltamavir caps, 30mg, 45mg and 75 mg  And  Favipiravir 200 mg/400mg/800mg Tablet.

INTERNATIONAL REGULATED COUNTRY

Well established corporate office in Mumbai-India, Moscow-Russia, Kiev-Ukraine, & Minsk-Belarus, Lok-Beta is able to cater regulated market operations in CIS Market covering almost all CIS countries.

  • CIS : Armenia, Belarus, Kazakhstan, Kirgizstan, Russia, Tajikistan, Turkmenistan, Ukraine, Uzbekistan

Fight against Novel Coronavirus ( COVID-19)

LOPIRAVIR - 250 mg / 125 mg (Lopinavir 200 mg & Ritonavir 50mg) Manufactured by J Duncan Healthcare Pvt. Ltd, Marketed by LOK-BETA Pharmaceuticals (I) Pvt. Ltd.

TINAROVIR - 125 mg (Lopinavir 200 mg & Ritonavir 50mg) Marketed and Manufactured by LOK-BETA Pharmaceuticals (I) Pvt. Ltd.

Producs :

The majority of products marketed are for the treatment and/or prevention of chronic and recurrent illness.

  • ARV’S (Anti – HIV)
  • Anti-Diabetic
  • Antibiotics
  • Immunosuppressants
  • Anti-Hypertensive
  • Gastroenterology
  • Anti -TB
  • Anti – Inflammatory

For details please visit Product menu

Business Module
  • Offer opportunities to our associates to run a small to medium sized profitable entrepreneurship by offering them technical know-how with the empowerment and accountability within the core values and system of the company.
  • Aiming to enable service towards broader segment of the pharmaceuticals & healthcare markets.
  • Products which matches its rigorous marketing, stringent quality norms and financial return criteria.
Methodology :

The company has extensive database and obtains regular feedback on customer purchasing patterns and preferences and doctor prescribing habits. These detailed information's are used to direct the company's promotional spend, sales force activity, product development programmes and to identify new product opportunities.